Cargando…

Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1–3): a retrospective cohort study conducted at a single center

BACKGROUND: This study aimed to investigate preoperative somatostatin analogs (SSAs) treatment on the surgical outcome in patients with acromegaly. METHODS: An analysis of 358 patients with acromegaly was conducted. The preoperative medical therapy group (81 patients) received SSA treatment for at l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Lian, Zhu, Huijuan, Xing, Bing, Gu, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585918/ https://www.ncbi.nlm.nih.gov/pubmed/28874187 http://dx.doi.org/10.1186/s12902-017-0205-3

Ejemplares similares

Surgical Experience of Transcranial Approaches to Large-to-Giant Pituitary Adenomas in Knosp Grade 4
por: Guan, Xiudong, et al.
Publicado: (2022)

Outcomes and Complications of Aggressive Resection Strategy for Pituitary Adenomas in Knosp Grade 4 With Transsphenoidal Endoscopy
por: Ouyang, Taohui, et al.
Publicado: (2021)

Craniopharyngioma in a patient with acromegaly due to a pituitary macroadenoma
por: El-Bilbeisi, Hazem, et al.
Publicado: (2010)

Pituitary Macroadenoma Presenting as Acromegaly and Subacute Pituitary Apoplexy: Case Report and Literature Review
por: Klimko, Artsiom, et al.
Publicado: (2020)

Radiological Knosp, Revised-Knosp, and Hardy–Wilson Classifications for the Prediction of Surgical Outcomes in the Endoscopic Endonasal Surgery of Pituitary Adenomas: Study of 228 Cases
por: Araujo-Castro, Marta, et al.
Publicado: (2022)

Acromegaly remission, SIADH and pituitary function recovery after macroadenoma apoplexy
por: Sanz-Sapera, E, et al.
Publicado: (2019)

Therapeutic Strategy for Cavernous Sinus-Invading Non-Functioning Pituitary Adenomas Based on the Modified Knosp Grading System
por: Hwang, Juyoung, et al.
Publicado: (2016)

Pituitary macroadenoma presenting with pituitary apoplexy, acromegaly and secondary diabetes mellitus - a case report
por: Nganga, Hudson Kamau, et al.
Publicado: (2013)

Place of Preoperative Treatment of Acromegaly with Somatostatin Analog on Surgical Outcome: A Systematic Review and Meta-Analysis
por: Pita-Gutierrez, Francisco, et al.
Publicado: (2013)

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study
por: Berton, Alessandro Maria, et al.
Publicado: (2022)

Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
por: Machado-Alba, J. E., et al.
Publicado: (2022)

Diagnosis of a Rare Case of Acromegaly Secondary to Pituitary Macroadenoma Debuting as Sudden DKA
por: Rivera Nazario, Ivan Augusto, et al.
Publicado: (2021)

A Rare Case of Thyrotropin Secreting Pituitary Macroadenoma Primarily Treated With Somatostatin Analogue
por: Elsheikh, Arwa Mahmoud, et al.
Publicado: (2021)

Thyrotoxicosis with absence of clinical features of acromegaly in a TSH- and GH-secreting, invasive pituitary macroadenoma
por: Johnston, Philip C, et al.
Publicado: (2015)

GH-secreting pituitary macroadenoma (acromegaly) associated with progressive dental malocclusion and refractory CPAP treatment
por: Miranda-Rius, Jaume, et al.
Publicado: (2017)

Stubborn hiccups as a sign of massive apoplexy in a naive acromegaly patient with pituitary macroadenoma
por: Simsek Bagir, Gulay, et al.
Publicado: (2017)

The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly
por: Colao, Annamaria, et al.
Publicado: (2015)

Endoscopic Endonasal Transcavernous Transoculomotor Triangle Approach for the Resection of a Knosp 4 Pituitary Adenoma
por: Heng, Lijun, et al.
Publicado: (2022)

Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center
por: Liu, Jie, et al.
Publicado: (2022)

Presurgical somatostatin receptor ligand treatment does not affect tumor consistency in GH-secreting pituitary macroadenomas
por: Araujo-Castro, Marta, et al.
Publicado: (2020)

FRI292 Asymptomatic TSH Secreting Pituitary Macroadenoma
por: Gautam, Bharat, et al.
Publicado: (2023)

Magnetic resonance imaging grading of pituitary macroadenoma – SIPAP classification revisited
por: Anwar, Shayan Sirat Maheen, et al.
Publicado: (2023)

Effects of somatostatin analog treatment on cardiovascular parameters in patients with acromegaly: A systematic review
por: Heidarpour, Maryam, et al.
Publicado: (2019)

Acromegaly: Pathophysiological Considerations and Treatment Options Including the Evolving Role of Oral Somatostatin Analogs
por: Daniel, Charles P., et al.
Publicado: (2023)

Using Growth Hormone Levels to Detect Macroadenoma in Patients with Acromegaly
por: Park, Ji Young, et al.
Publicado: (2014)

Efficacy of cabergoline add-on therapy in patients with acromegaly resistance to somatostatin analogs treatment and the review of literature
por: Kizilgul, Muhammed, et al.
Publicado: (2022)

The Future of Somatostatin Receptor Ligands in Acromegaly
por: Gadelha, Monica R, et al.
Publicado: (2021)

LBODP075 Vanishing Pituitary Macroadenoma
por: Naik, Vaishali Shashikant
Publicado: (2022)

Pancreatic ACTH Hypersecretion and Pituitary Macroadenoma
por: Bettale, Chiara M, et al.
Publicado: (2023)

Clinical applications of somatostatin analogs for growth hormone-secreting pituitary adenomas
por: Wang, Ji-wen, et al.
Publicado: (2014)

Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients
por: Neggers, Sebastian J. C. M. M., et al.
Publicado: (2011)

Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysis
por: Gurel, Michelle H., et al.
Publicado: (2017)

Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs
por: Gadelha, Mônica, et al.
Publicado: (2020)

Combined treatment of somatostatin analogues with pegvisomant in acromegaly
por: Franck, S. E., et al.
Publicado: (2015)

Novel Somatostatin Receptor Ligands Therapies for Acromegaly
por: Paragliola, Rosa Maria, et al.
Publicado: (2018)

Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas
por: Elhateer, H., et al.
Publicado: (2008)

Pituitary Macroadenoma Presenting with Multiple Psychiatric Complications
por: Sood, Mamta, et al.
Publicado: (2015)

Vanishing Pituitary Macroadenoma: A Case Report
por: Sieg, Emily P, et al.
Publicado: (2016)

Chiasmal herniation following treatment of pituitary macroadenoma
por: Tabak, Marjolein, et al.
Publicado: (2020)

Plurihormonal pituitary macroadenoma: a case report
por: Allehaibi, Ebtesam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m74832pcvpmgplch42ob0fc12b